Mrinal M. Patnaik

19.8k total citations · 1 hit paper
479 papers, 9.0k citations indexed

About

Mrinal M. Patnaik is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Mrinal M. Patnaik has authored 479 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 355 papers in Hematology, 237 papers in Genetics and 84 papers in Molecular Biology. Recurrent topics in Mrinal M. Patnaik's work include Acute Myeloid Leukemia Research (281 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (163 papers) and Chronic Myeloid Leukemia Treatments (91 papers). Mrinal M. Patnaik is often cited by papers focused on Acute Myeloid Leukemia Research (281 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (163 papers) and Chronic Myeloid Leukemia Treatments (91 papers). Mrinal M. Patnaik collaborates with scholars based in United States, Canada and France. Mrinal M. Patnaik's co-authors include Ayalew Tefferi, Animesh Pardanani, Terra L. Lasho, Curtis A. Hanson, Christy M. Finke, Rhett P. Ketterling, Naseema Gangat, Stephan Moll, Abhishek A. Mangaonkar and Mark R. Litzow and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mrinal M. Patnaik

435 papers receiving 8.9k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population

2021 218 citations Puru Rattan, Daniel D. Penrice et al. Hepatology Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mrinal M. Patnaik United States	51	5.5k	4.0k	2.7k	1.4k	1.1k	479	9.0k
Richard Szydlo United Kingdom	50	6.1k 1.1×	3.4k 0.9×	1.3k 0.5×	1.8k 1.3×	1.3k 1.1×	197	8.7k
Bruno Varet France	37	4.1k 0.7×	2.6k 0.7×	1.7k 0.6×	1.0k 0.7×	1.4k 1.3×	145	7.6k
Alberto Bosi Italy	57	6.1k 1.1×	3.6k 0.9×	2.3k 0.9×	1.0k 0.7×	1.8k 1.6×	321	10.5k
James L. Zehnder United States	47	3.2k 0.6×	1.8k 0.5×	2.2k 0.8×	744 0.5×	1.4k 1.2×	231	8.4k
Andreas Buser Switzerland	30	2.9k 0.5×	3.2k 0.8×	2.0k 0.7×	1.3k 0.9×	828 0.7×	151	6.2k
Mauricette Michallet France	50	6.9k 1.3×	2.2k 0.6×	2.0k 0.7×	529 0.4×	1.8k 1.6×	311	10.0k
Andrew Grigg Australia	48	5.0k 0.9×	3.8k 0.9×	1.3k 0.5×	1.8k 1.3×	1.2k 1.0×	274	8.8k
Josy Reiffers France	48	6.6k 1.2×	3.2k 0.8×	1.7k 0.6×	1.5k 1.1×	1.3k 1.1×	223	9.1k
Giorgio La Nasa Italy	45	2.3k 0.4×	2.7k 0.7×	1.8k 0.7×	401 0.3×	899 0.8×	275	6.7k
Françoise Huguet France	39	5.6k 1.0×	3.2k 0.8×	1.2k 0.5×	1.6k 1.1×	559 0.5×	179	8.0k

Countries citing papers authored by Mrinal M. Patnaik

Since Specialization

Citations

This map shows the geographic impact of Mrinal M. Patnaik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mrinal M. Patnaik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mrinal M. Patnaik more than expected).

Fields of papers citing papers by Mrinal M. Patnaik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mrinal M. Patnaik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mrinal M. Patnaik. The network helps show where Mrinal M. Patnaik may publish in the future.

Co-authorship network of co-authors of Mrinal M. Patnaik

This figure shows the co-authorship network connecting the top 25 collaborators of Mrinal M. Patnaik. A scholar is included among the top collaborators of Mrinal M. Patnaik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mrinal M. Patnaik. Mrinal M. Patnaik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marshall, Catherine H., Emmanuel S. Antonarakis, & Mrinal M. Patnaik. (2025). Radiotherapeutics, clonal hematopoiesis, and risk of hematologic malignancies: The good, the bad, the ugly. Blood Reviews. 70. 101269–101269. 2 indexed citations

He, Rong, Patricia T. Greipp, David S. Viswanatha, et al.. (2024). Molecular and clinical characterization of ETNK1-mutated myeloid neoplasms: the Mayo Clinic experience. Blood Advances. 8(18). 4807–4811. 2 indexed citations

Csizmar, Clifford M., Mark E. Gurney, Rashmi Kanagal‐Shamanna, et al.. (2024). Prognostic Impact of the Number of TET2 Mutations in Myelodysplastic and Myeloproliferative Chronic Myelomonocytic Leukemia (CMML). Blood. 144(Supplement 1). 1820–1820. 1 indexed citations

Tefferi, Ayalew, Aref Al‐Kali, Mrinal M. Patnaik, et al.. (2023). Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases. American Journal of Hematology. 99(1). 21–27. 2 indexed citations

Mendez, Lourdes & Mrinal M. Patnaik. (2023). Clonal Hematopoiesis: Origins and determinants of evolution. Leukemia Research. 129. 107076–107076. 3 indexed citations

Badar, Talha, James M. Foran, David S. Viswanatha, et al.. (2023). Clinical and molecular correlates of somatic and germline <i>DDX41</i> variants in patients and families with myeloid neoplasms. Haematologica. 108(11). 3033–3043. 10 indexed citations

Patnaik, Mrinal M. & Ayalew Tefferi. (2023). Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management. American Journal of Hematology. 98(4). 681–689. 14 indexed citations

Al‐Kali, Aref, Dragan Jevremović, Phuong L. Nguyen, et al.. (2023). IPSS-M - Use for Predicting Survival and Progression in Patients with Ccus - a Retrospective Multi-Institutional Study. Blood. 142(Supplement 1). 4590–4590. 2 indexed citations

Binder, Moritz, Ryan M. Carr, Terra L. Lasho, et al.. (2022). Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemia. Nature Communications. 13(1). 1434–1434. 14 indexed citations

10.

Nadiminti, Kalyan, Mehrdad Hefazi, Yogesh Jethava, et al.. (2021). A novel Iowa–Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction. Blood Cancer Journal. 11(11). 183–183. 2 indexed citations

11.

Patnaik, Mrinal M., Tariq I. Mughal, Christopher Brooks, Ross Lindsay, & Naveen Pemmaraju. (2021). Targeting CD123 in hematologic malignancies: identifying suitable patients for targeted therapy. Leukemia & lymphoma. 62(11). 2568–2586. 14 indexed citations

12.

Rattan, Puru, Daniel D. Penrice, Joseph Ahn, et al.. (2021). Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population. Hepatology Communications. 6(2). 399–410. 218 indexed citations breakdown →

13.

Scott, Jeffrey F., Konstantin V. Grigoryan, John G. Muzic, et al.. (2020). Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants. JAMA Dermatology. 156(6). 631–631. 11 indexed citations

14.

Bezerra, Evandro D., Giacomo Coltro, Terra L. Lasho, et al.. (2020). Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly annotated patients. Leukemia. 35(2). 644–649. 7 indexed citations

15.

Baidoun, Firas, Dong Chen, Mrinal M. Patnaik, et al.. (2019). Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U): single center experience. Leukemia & lymphoma. 60(10). 2483–2487. 2 indexed citations

16.

Tefferi, Ayalew, Jeanne Palmer, James L. Slack, et al.. (2018). Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis. American Journal of Hematology. 93(5). 649–654. 28 indexed citations

17.

Saadeh, Salwa, Mrinal M. Patnaik, Hassan B. Alkhateeb, et al.. (2018). Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes. American Journal of Hematology. 93(12). E398–E401. 1 indexed citations

18.

Patnaik, Mrinal M.. (2017). The importance of FLT3 mutational analysis in acute myeloid leukemia. Leukemia & lymphoma. 59(10). 2273–2286. 65 indexed citations

19.

Gangat, Naseema, Mrinal M. Patnaik, Kebede H. Begna, et al.. (2015). Primary Myelodysplastic Syndromes. Mayo Clinic Proceedings. 90(12). 1623–1638. 14 indexed citations

20.

Lim, Ken-Hong, Ayalew Tefferi, Terra L. Lasho, et al.. (2009). Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood. 113(23). 5727–5736. 369 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact